Literature DB >> 11896585

Differences in DNA binding properties between E2F1 and E2F4 specify repression of the Mcl-1 promoter.

Rhonda Croxton1, Yihong Ma, W Douglas Cress.   

Abstract

E2F1 is a potent inducer of apoptosis whereas its relative, E2F4, generally does not promote cell death. Other work from our laboratory has demonstrated that E2F1 can directly bind and represss the Mcl-1 promoter - contributing to E2F1-mediated apoptosis. Here we show that while E2F1 can repress the Mcl-1 promoter, other members of the E2F family (such as E2F4) cannot. Characterization of the Mcl-1 promoter demonstrates that the -143/+10 region is critical for E2F1-mediated downregulation. We demonstrate that the ability of E2F1 to repress the Mcl-1 promoter correlates with its ability to bind within the required -143/+10 region of this promoter. In contrast, E2F4 is unable to bind to the -143/+10 region of the Mcl-1 promoter. We propose that E2F4 is unable to repress the Mcl-1 promoter primarily as a result of insufficient binding to the essential regulatory region. This is the first evidence of DNA binding specificity among E2F family members that results in differential regulation of a naturally occurring promoter.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11896585     DOI: 10.1038/sj.onc.1205232

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  9 in total

Review 1.  Role of cell cycle re-entry in neurons: a common apoptotic mechanism of neuronal cell death.

Authors:  Jaume Folch; Felix Junyent; Ester Verdaguer; Carme Auladell; Javier G Pizarro; Carlos Beas-Zarate; Mercè Pallàs; Antoni Camins
Journal:  Neurotox Res       Date:  2011-10-01       Impact factor: 3.911

2.  The protein kinase C delta catalytic fragment targets Mcl-1 for degradation to trigger apoptosis.

Authors:  Leonid A Sitailo; Shalini S Tibudan; Mitchell F Denning
Journal:  J Biol Chem       Date:  2006-08-10       Impact factor: 5.157

3.  A small-molecule E2F inhibitor blocks growth in a melanoma culture model.

Authors:  Yihong Ma; Courtney A Kurtyka; Sandhya Boyapalle; Shen-Shu Sung; Harshani Lawrence; Wayne Guida; W Douglas Cress
Journal:  Cancer Res       Date:  2008-08-01       Impact factor: 12.701

4.  DNA damage response and MCL-1 destruction initiate apoptosis in adenovirus-infected cells.

Authors:  Andrea Cuconati; Chandreyee Mukherjee; Denise Perez; Eileen White
Journal:  Genes Dev       Date:  2003-11-21       Impact factor: 11.361

5.  EDD enhances cell survival and cisplatin resistance and is a therapeutic target for epithelial ovarian cancer.

Authors:  Amber Bradley; Hui Zheng; Angela Ziebarth; Wayne Sakati; Melissa Branham-O'Connor; Joe B Blumer; Yuying Liu; Emily Kistner-Griffin; Cristian Rodriguez-Aguayo; Gabriel Lopez-Berestein; Anil K Sood; Charles N Landen; Scott T Eblen
Journal:  Carcinogenesis       Date:  2013-12-30       Impact factor: 4.944

Review 6.  Targeting BCL-2 in B-cell malignancies and overcoming therapeutic resistance.

Authors:  Isha Kapoor; Juraj Bodo; Brian T Hill; Eric D Hsi; Alexandru Almasan
Journal:  Cell Death Dis       Date:  2020-11-02       Impact factor: 8.469

7.  E2f2 Attenuates Apoptosis of Activated T Lymphocytes and Protects from Immune-Mediated Injury through Repression of Fas and FasL.

Authors:  Noor Mustafa; Jone Mitxelena; Arantza Infante; Olatz Zenarruzabeitia; Ainhoa Eriz; Ainhoa Iglesias-Ara; Ana M Zubiaga
Journal:  Int J Mol Sci       Date:  2021-12-28       Impact factor: 5.923

8.  Reduced FANCD2 influences spontaneous SCE and RAD51 foci formation in uveal melanoma and Fanconi anaemia.

Authors:  P Gravells; L Hoh; S Solovieva; A Patil; E Dudziec; I G Rennie; K Sisley; H E Bryant
Journal:  Oncogene       Date:  2013-01-14       Impact factor: 9.867

9.  Expression of integrin alpha 10 is transcriptionally activated by pRb in mouse osteoblasts and is downregulated in multiple solid tumors.

Authors:  B E Engel; E Welsh; M F Emmons; P G Santiago-Cardona; W D Cress
Journal:  Cell Death Dis       Date:  2013-11-28       Impact factor: 8.469

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.